Sentences with phrase «treatment of multiple myeloma»

These new therapies have used bortezomib, a proteasome inhibitor that is already approved by the FDA for treatment of multiple myeloma.

Through its multiple myeloma initiative and other grant programs, CRI is supporting several basic and clinical studies that are advancing the understanding and immunologic treatment of multiple myeloma.

At present, he is leading multiple efforts studying the use of new agents and pioneered the development of lenalidomide, bortezomib, and dexamethasone (so called RVD), which is now widely used in the upfront treatment of multiple myeloma.

The implication of NETs in myeloma progression and targeting a process of NET formation for treatment of multiple myeloma are under investigation.

«We remain committed to exploring Kyprolis in combination with other agents to advance the treatment of multiple myeloma,» Harper said.

DeCicco - Skinner's research suggests a new approach for the treatment of multiple myeloma.

A new therapeutic approach tested by a team from Maisonneuve - Rosemont Hospital (CIUSSS - EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.

«Cancer treatment: Therapeutic approach gives hope for the treatment of multiple myeloma.»

«Because thalidomide is now used for the treatment of multiple myeloma and leprosy, identification of its direct target may allow rational design of more effective thalidomide derivatives without teratogenic activity,» they report.

One of the biggest questions about the treatment of multiple myeloma, a form of blood cancer, is why nearly all patients treated with current therapies eventually suffer relapse.

In the 1990s the U.S. Food and Drug Administration approved its use in the treatment of both multiple myeloma (a form of cancer that affects plasma cells) and the complications of leprosy.

P - BCMA - 101 is Poseida's lead CAR - T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma.

FDA approves the drug bortezomib (Velcade) for the treatment of multiple myeloma.

Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way.

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer Center...

Today we speak with Steven T. Rosen, MD, about a couple of the projects he and his group are working on, repurposing old drugs for the treatment of multiple myeloma, that will be presented this year at ASH.

When signs or symptoms appear, the treatment of multiple myeloma may be done in phases:

Daratumumab and elotuzumab are monoclonal antibodies used in the treatment of multiple myeloma and other plasma cell neoplasms.

Panobinostat is an HDAC inhibitor used in the treatment of multiple myeloma and other plasma cell neoplasms.

Bortezomib, carfilzomib, and ixazomib are proteasome inhibitors used in the treatment of multiple myeloma and other plasma cell neoplasms.

Dr. Remiszewski is the co-inventor of panobinostat (Farydak ®), which the FDA approved in February 2015 for the treatment of multiple myeloma.

This work led to the development of Velcade ®, now widely used in the treatment of multiple myeloma.

He was also a co-founder of ProScript Inc., which discovered the drug Velcade for the treatment of multiple myeloma.

All in all, the researchers maintain that their results support the use of sorafenib in combination with other drugs in the treatment of multiple myeloma.